+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Advance in research on the correlation between genotypes of susceptible mutations and clinical phenotype of familial adenomatous polyposis



Advance in research on the correlation between genotypes of susceptible mutations and clinical phenotype of familial adenomatous polyposis



Zhonghua Yi Xue Yi Chuan Xue Za Zhi 34(6): 919-923



Familial adenomatous polyposis (FAP) is one of the most common hereditary colorectal cancers. Its intestinal and extra-intestinal manifestations are correlated with mutation sties of the APC gene. Potential gene modulation sites in patients who have typical clinical manifestations but with unidentified APC mutations are also discussed, which included MUTYH gene, AXIN gene and certain epigenetic changes. With the generalization of Precision Medicine, to offer individualized treatment and surveillance strategy based on the genotype-phenotype correlation will be of great value for FAP patients. This review focuses on the research advance in genotype - phenotype correlation studies of FAP patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045294139

Download citation: RISBibTeXText

PMID: 29188631


Related references

Seven novel mutations in the APC gene of Portuguese families with familial adenomatous polyposis: Correlation with phenotype. Cancer Genetics & Cytogenetics 111(2): 152-156, 1999

Screening for mutations of the adenomatous polyposis coli gene in 67 Italian familial adenomatous polyposis Further evidence of complex genotype-phenotype correlations. Gastroenterology 114(4 Part 2): A566, 1998

Correlation between APC germline mutation and clinical phenotype in familial adenomatous polyposis. Kawasaki Igakkai Shi 27(4): 279-292, 2001

Clinical features of familial adenomatous polyposis: Genotype-phenotype correlation and chemoprevention. Stomach & Intestine 32(4): 543-550, 1997

Arylamine N-acetyltransferase genotype in familial adenomatous polyposis Correlation with clinical phenotype. Gastroenterology 116(4 Part 2): A448, 1999

Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. American Journal of Pathology 160(6): 2055-2061, 2002

Prospective evaluation of duodenal polyposis progression in familial adenomatous polyposis patients, and genotype-phenotype correlation. Gastroenterology 118(4 Suppl 2 Part 1): AGA A656, 2000

Germ line mutations of adenomatous of adenomatous polyposis coli apc gene in a series of french propositi for familial adenomatous polyposis. Gastroenterology 102(4 Part 2): A384, 1992

APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 40(4): 521-525, 1997

Genotype-phenotype correlation in familial adenomatous polyposis. Gastroenterology 108(4 Suppl. ): A459, 1995

APC germ-line mutations in southern Spanish patients with familial adenomatous polyposis: genotype-phenotype correlations and identification of eight novel mutations. Genetic Testing 9(1): 37-40, 2005

Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Human Molecular Genetics 2(7): 925-931, 1993

The relationships between phenotypic expression in patients with familial adenomatous polyposis (FAP) and the site of mutations in the adenomatous polyposis coli (APC) gene. Annals of Surgery 229(3): 445-446, 1999

Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression. American Journal of Gastroenterology 101(12): 2810-2817, 2006

Analysis of adenomatous polyposis coli gene mutations in familial adenomatous polyposis patients at increased risk for periampullary neoplasia. Proceedings of the American Association for Cancer Research Annual Meeting 34: 517, 1993